Thyroid hormone role on cerebellar development and maintenance: A perspective based on transgenic mouse models

Frontiers in Endocrinology

Volumn 5, Issue MAY, 2014, Pages

  Faustino, Larissa C ^a   Ortiga Carvalho, Tania M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER; THYROID HORMONE; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA; THYROTROPIN; THYROXINE; THYROXINE DEIODINASE;

BRAIN DEVELOPMENT; CEREBELLUM DEVELOPMENT; CONGENITAL HYPOTHYROIDISM; GENE EXPRESSION; HORMONE TRANSPORT; HUMAN; LOCOMOTION; MOUSE; NONHUMAN; ONTOGENY; PHENOTYPE; PURKINJE CELL; REVIEW; TRANSGENIC ANIMAL;

EID: 84905369460     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00075     Document Type: Review

References (92)

1. Lazar M. Thyroid hormone action: a binding contact. J Clin Invest (2003) 122:497-9. doi: 10.1172/JCI19479
2. Brent GA. Mechanisms of thyroid hormone action. J Clin Invest (2012) 122(9):3035-43. doi:10.1172/JCI60047
3. Anderson GW, Schoonover CM, Jones SA. Control of thyroid hormone action in the developing rat brain. Thyroid (2003) 13(11):1039-56. doi:10.1089/105072503770867219
4. de Escobar GM, Obregón MJ, del Rey FE. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab (2004) 18(2):225-48. doi:10.1016/j.beem.2004.03.012
5. Bernal J. Thyroid hormones and brain development. Vitam Horm (2005) 71:95-122. doi:10.1016/S0083-6729(05)71004-9
6. Diez D, Grijota-Martinez C, Agretti P, Marco GD, Tonacchera M, Pinchera A, et al. Thyroid hormone action in the adult brain: gene expression profiling of the effects of single and multiple doses of triiodo-l-thyronine in the rat striatum. Endocrinology (2008) 149(8):3989-4000. doi:10.1210/en.2008-0350
7. Altman J, Bayer SA. Development of the Cerebellar System in Relation to its Evolution, Structure, and Functions. Boca Raton: CRC Press (1997).
8. Tavano A, Grasso R, Gagliardi C, Triulzi F, Bresolin N, Fabbro F, et al. Disorders of cognitive and affective development in cerebellar malformations. Brain (2007) 130(10):2646-60. doi:10.1093/brain/awm201
9. Legrand J. Effects of thyroid hormones on central nervous system development. In: Yanai J, editor. Neurobehavioral Teratology. Amsterdam: Elsevier (1984). p. 31-363.
10. Sillitoe RV, Joyner AI. Morphology, molecular codes, and circuitry produce the three-dimensional complexity of the cerebellum. Annu Rev Cell Dev Biol (2007) 23:549-77. doi:10.1146/annurev.cellbio.23.090506.123237
11. Koibuchi N, Ikeda Y. Hormones and cerebellar development. In: Manto M, Gruol D, Schmahmann JD, Koibuchi N, editors. Handbook of the Cerebellum and Cerebellar Disorders. New York, NY: Springer (2013). p. 319-39.
12. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev (2010) 31(2):139-70. doi:10.1210/er.2009-0007
13. Liu Y, Xia X, Fondell JD, Yen PM. Thyroid hormone-regulated target genes have distinct patterns of coactivator recruitment and histone acetylation. Mol Endocrinol (2006) 20(3):483-90. doi:10.1210/me.2005-0101
14. Bradley DJ, Towle HC, Young WS. Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta-2 subtype in the mammalian nervous system. J Neurosci (1992) 12:2288-302.
15. Chan S, Kachilele S, McCabe CJ, Tannahill LA, Boelaert K, Gittoes NJ, et al. Early expression of thyroid hormone deiodinases and receptors in human fetal cerebral cortex. Brain Res Dev Brain Res (2002) 138:109-16. doi:10.1016/S0165-3806(02)00459-5
16. Quignodon L, Grijota-Martinez C, Compe E, Guyot R, Allioli N, Laperriere D, et al. A combined approach identifies a limited number of new thyroid hormone target genes in post-natal mouse cerebellum. J Mol Endocrinol (2007) 39:17-28. doi:10.1677/JME-06-0054
17. Davis PJ, Davis FB, Cody V. Membrane receptors mediating thyroid hormone action. Trends Endocrinol Metab (2005) 16(9):429-35. doi:10.1016/j.tem.2005.09.0072
18. Farwell AP, Dubord-Tomasetti S, Pietrzykowski AZ, Leonard JL. Dynamic nongenomic actions of thyroid hormone in the developing rat brain. Endocrinology (2006) 147(5):2567-74. doi:10.1210/en.2005-1272
19. Gothe S, Wang Z, Ng L, Kindblom JM, Barros AC, Ohlsson C, et al. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev (1999) 13:1329-41. doi:10.1101/gad.13.10.1329
20. Farwell AP, Dubord-Tomasetti SA, Pietrzykowski AZ, Stachelek SJ, Leonard JL. Regulation of cerebellar neuronal migration and neurite outgrowth by thyroxine and 3,3',5'-triiodothyronine. Brain Res Dev Brain Res (2005) 154(11):121-35. doi:10.1016/j.devbrainres.2004.07.016
21. Galton VA, Schneider MJ, Clark AS, St Germain DL. Life without thyroxin to 3,5,3'-triiodothyronine conversion: studies in mice devoid of 5'-deiodinases. Endocrinology (2009) 150:2958-63. doi:10.1210/en.2008-1572
22. Friesema EC, Gueters A, Biebermann H, Krude H, von Moers A, Reeser M, et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet (2004) 364:1435-7. doi:10.1016/S0140-6736(04)17226-7
23. Heuer H, Maier MK, Iden S, Mittag J, Friesema EC, Visser TJ, et al. The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology (2005) 146:1701-6. doi:10.1210/en.2004-1179
24. Obregón MJ, Mallol J, Pastor R, de Escobar GM, del Rey GE. l-Thyroxine and 3,5,3'-triiodo-l-thyronine in rat embryos before onset of fetal thyroid function. Endocrinology (1984) 144:305-7. doi:10.1210/endo-114-1-305
25. Piosik PA, van Groenigen M, van Doorn J, Baas F, de Vijlder JJ. Effects of maternal thyroid status on thyroid hormones and growth in congenitally hypothyroid goat fetuses during the second half of gestation. Endocrinology (1997) 138:5-11. doi:10.1210/endo.138.1.4843
26. Contempré B, Jauniaux E, Calvo R, Jurkovic D, Campbell S, de Escobar GM. Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab (1993) 77:1719-22. doi:10.1210/jcem.77.6.8263162
27. Kester MH, Martinez de Mena R, Obregon MJ, Marinkovic D, Howatson A, Visser TJ, et al. Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab (2004) 89:3117-28. doi:10.1210/jc.2003-031832
28. Boyages SC, Halpern JP. Endemic cretinism: toward a unifying hypothesis. Thyroid (1993) 3:59-69. doi:10.1089/thy.1993.3.59
29. LaFranchi S. Congenital hypothyroidism: etiologies, diagnosis, and management. Thyroid (1999) 9:735-40. doi:10.1089/thy.1999.9.735
30. Porterfield SP, Hendrich CE. The role of thyroid hormones in prenatal and neonatal neurological development - current perspectives. Endocr Rev (1993) 14:94-106. doi:10.1210/edrv-14-1-94
31. Bernal J. Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab (2007) 3:249-59. doi:10.1038/ncpendmet0424
32. Mansouri A, Chowdhury K, Gruss P. Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet (1998) 19:87-90. doi:10.1038/ng0598-87
33. Poguet AL, Legrand C, Feng X, Yen PM, Meltzer P, Samarut J, et al. Microarray analysis of knockout mice identifies cyclin D2 as a possible mediator for the action of thyroid hormone during the postnatal development of the cerebellum. Dev Biol (2003) 254:188-99. doi:10.1016/S0012-1606(02)00039-8
34. Friedrichsen S, Christ S, Heuer H, Schäfer MK, Mansouri A, Bauer K, et al. Regulation of iodothyronine deiodinases in the Pax8-/- mouse model of congenital hypothyroidism. Endocrinology (2003) 144(3):777-84. doi:10.1210/en.2002-220715
35. Horn S, Kersseboom S, Mayer S, Muller J, Groba C, Trajkovic-Arsic M, et al. Tetrac can replace thyroid hormone during brain development in mouse mutants deficient in the thyroid hormone transporter Mct8. Endocrinology (2013) 154(2):968-79. doi:10.1210/en.2012-1628
36. Dumitrescu AM, Liao XH, Weiss RE, Millen K, Refetoff S. Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology (2006) 147:4036-43. doi:10.1210/en.2006-0390
37. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM, et al. Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest (2007) 117(3):627-35. doi:10.1172/JCI28253
38. Mayerl S, Müller J, Bauer R, Richert S, Kassmann CM, Darras VM, et al. Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis. J Clin Invest (2014) 124(5):1987-99. doi:10.1172/JCI70324
39. Mayerl S, Visser TJ, Darras VM, Horn S, Heuer H. Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain. Endocrinology (2012) 153(3):1528-37. doi:10.1210/en.2011-1633
40. Braun D, Wirth EK, Wohlgemuth F, Reix N, Klein MO, Gruters A, et al. Aminoaciduria, but normal thyroid hormone levels and signalling, in mice lacking the amino acid and thyroid hormone transporter Slc7a8. Biochem J (2011) 439(2):249-55. doi:10.1042/BJ20110759
41. Guadano-Ferraz A, Obregon MJ, St Germain DL, Bernal J. The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc Natl Acad Sci U S A (1997) 94:10391-6. doi:10.1073/pnas.94.19.10391
42. Galton VA, Wood ET, Germain EAS, Withrow CA, Aldrich G, Germain GMS, et al. Thyroid hormone homeostasis and action in the type 2 deiodinase-deficient rodent brain during development. Endocrinology (2007) 148:3080-8. doi:10.1210/en.2006-1727
43. Hernandez A, Martinez ME, Fiering S, Galton VA, Germain DS. Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Invest (2006) 116(2):476-84. doi:10.1172/JCI26240
44. Hernandez A, Martinez E, Fiering S, Galton VA, St Germain DL. Type 3 deiodinase deficiency results in functional abnormalities at multiple levels of the thyroid axis. Endocrinology (2007) 148:5680-7. doi:10.1210/en.2007-0652
45. Peeters RP, Hernandez A, Lily N, Michelle M, David SS, Mei P, et al. Cerebellar abnormalities in mice lacking type 3 deiodinase and partial reversal of phenotype by deletion of thyroid hormone receptor alpha1. Endocrinology (2013) 154(1):550-61. doi:10.1210/en.2012-1738
46. Morte B, Manzano J, Scanlan T, Vennström B, Bernal J. Deletion of the thyroid hormone receptor a1 prevents the structural alterations of the cerebellum induced by hypothyroidism. Proc Natl Acad Sci U S A (2002) 99(6):3985-9. doi:10.1073/pnas.062413299
47. Wilkstrom L, Johansson C, Salto C, Barlow C, Campo-Barros A, Baas F, et al. Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1. EMBO J (1998) 17:455-61. doi:10.1093/emboj/17.2.455
48. Forrest D, Hanebuth E, Smeyne RJ, Everds N, Stewart CL, Wehner JM, et al. Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: evidence for tissue-specific modulation of receptor function. EMBO J (1996) 15(12):3006-15.
49. Sandhofer C, Schwartz HL, Mariash CN, Forrest D, Oppenheimer JH. Beta receptor isoforms are not essential for thyroid hormone-dependent acceleration of PCP-2 and myelin basic protein gene expression in the developing brains of neonatal mice. Mol Cell Endocrinol (1998) 137:109-15. doi:10.1016/S0303-7207(98)00005-7
50. Hashimoto K, Curty FH, Borges PP, Lee CE, Abel ED, Elmquist JK, et al. An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proc Natl Acad Sci U S A (2001) 98:3998-4003. doi:10.1073/pnas.051454698
51. Portella A, Carvalho F, Faustino LC, Ortiga-Carvalho TM, Gomes FC. Thyroid hormone receptor beta mutation causes severe impairment of cerebellar development. Mol Cell Neurosci (2010) 44(1):68-77. doi:10.1016/j.mcn.2010.02.004
52. Itoh Y, Esaki T, Kaneshige M, Suzuki H, Cook M, Sokoloff L, et al. Brain glucose utilization in mice with a targeted mutation in the thyroid hormone alpha or beta receptor gene. Proc Natl Acad Sci U S A (2001) 98(17):9913-8. doi:10.1073/pnas.171319498
53. Tinnikov A, Nordström K, Thorén P, Kindblom JM, Malin S, Rozell B, et al. Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1. EMBO J (2002) 21:5079-87. doi:10.1093/emboj/cdf523
54. Venero C, Guadaño-Ferraz A, Herrero AI, Nordström K, Manzano J, del Escobar GM, et al. Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor alpha1 can be ameliorated by T3 treatment. Genes Dev (2005) 19(18):2152-63. doi:10.1101/gad.346105
55. Quignodon L, Vincent S, Winter H, Samarut J, Flamant F. A point mutation in the activation function 2 domain of thyroid hormone receptor alpha1 expressed after CRE-mediated recombination partially recapitulates hypothyroidism. Mol Endocrinol (2007) 21:2350-60. doi:10.1210/me.2007-0176
56. Picou F, Fauquier T, Chatonnet F, Flamant F. A biomodal influence of thyroid hormone on cerebellum oligodendrocyte differentiation. Mol Endocrinol (2012) 26:608-18. doi:10.1210/me.2011-1316
57. Avci HX, Lebrun C, Wehrle R, Doulazmi M, Chatonnet F, Morel MP, et al. Thyroid hormone triggers the developmental loss of axonal regenerative capacity via thyroid hormone receptor a1 and Krüppel-like factor 9 in Purkinje cells. Proc Natl Acad Sci U S A (2012) 109(35):14206-11. doi:10.1073/pnas.1119853109
58. Fauquier T, Chatonnet F, Picou F, Lamonerie T, Flamant F. Purkinje cells and Bergmann glia are primary targets of the TRa1 thyroid hormone receptor during mouse cerebellum postnatal development. Development (2014) 141:166-75. doi:10.1242/dev.103226
59. Nishihara E, Yoshida-Komiya H, Chan CS, Liao L, Davis RL, O'Malley BW, et al. SRC-1 null mice exhibit moderate motor dysfunction and delayed development of cerebellar Purkinje cells. J Neurosci (2003) 23(1):213-22.
60. Nicholson JL, Altman J. The effects of early hypo- and hyperthyroidism on the development of rat cerebellar cortex. I. Cell proliferation and differentiation. Brain Res (1972) 44(1):13-23. doi:10.1016/0006-8993(72)90362-9
61. Lauder JM. The effects of early hypo- and hyperthyroidism on the development of rat cerebellar cortex. III. Kinetics of cell proliferation in the external granular layer. Brain Res (1977) 126:31-51. doi:10.1016/0006-8993(77)90213-X
62. Lauder JM. Effects of early hypo- and hyperthyroidism on development of rat cerebellar cortex. IV. The parallel fibers. Brain Res (1978) 142(1):25-39. doi:10.1016/0006-8993(78)90174-9
63. Heuer H, Mason CA. Thyroid hormone induces cerebellar Purkinje cell dendritic development via the thyroid hormone receptor a1. J Neurosci (2003) 23(33):10604-12.
64. Martinez R, Gomes FC. Proliferation of cerebellar neurons induced by astrocytes treated with thyroid hormone is mediated by a cooperation between cell contact and soluble factors and involves the epidermal growth factor-protein kinase a pathway. J Neurosci (2005) 80:341-9. doi:10.1523/jneurosci.3358-03.2004
65. Wang Y, Zhong J, Xu H, Wei W, Dong J, Yu F, et al. Perinatal iodine deficiency and hypothyroidism increase cell apoptosis and alter doublecortin and reelin protein expressions in rat cerebellum. Arch Med Res (2012) 43(4):255-64. doi:10.1016/j.arcmed.2012.05.002
66. Alvarez-Dolado M, Cuadrado A, Navarro-Yubero C, Sonderegger P, Furley AJ, Bernal J, et al. Regulation of the L1 cell adhesion molecule by thyroid hormone in the developing brain. Mol Cell Neurosci (2000) 16:499-514. doi:10.1006/mcne.2000.0879
67. Martinez R, Gomes FCA. Neuritogenesis induced by thyroid hormone-treated astrocytes is mediated by epidermal growth factor/mitogen-activated protein kinase-phosphatidylinositol 3-kinase pathways and involves modulation of extracellular matrix proteins. J Biol Chem (2002) 277:49311-8. doi:10.1074/jbc.M209284200
68. Chakraborty G, Magagna-Poveda A, Parrat C, Umans JG, MacLusky NJ, Scharfman HE. Reduced hippocampal brain-derived neurotrophic factor (BDNF) in neonatal rats after prenatal exposure to propylthiouracil (PTU). Endocrinology (2012) 153(3):1311-6. doi:10.1210/en.2011-1437
69. Martinez R, Eller C, Viana NB, Gomes FC. Thyroid hormone induces cerebellar neuronal migration and Bergmann glia differentiation through epidermal growth factor/mitogen-activated protein kinase pathway. Eur J Neurosci (2011) 33(1):26-35. doi:10.1111/j.1460-9568.2010.07490
70. van der Deure WM, Peeters RP, Visser TJ. Molecular aspects of thyroid hormone transporters, including MCT8, MCT10, and OATPs, and the effects of genetic variation in these transporters. J Mol Endocrinol (2010) 44(1):1-11. doi:10.1677/JME-09-0042
71. Schweizer U, Kohrle J. Function of thyroid hormone transporters in the central nervous system. Biochim Biophys Acta (2013) 1830(7):3965-73. doi:10.1016/j.bbagen.2012.07.015
72. Friesema ECH, Jansen J, Heuer H, Trajkovic M, Bauer K, Visser TJ. Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8. Nat Clin Pract Endocrinol Metab (2006) 2(9):512-23. doi:10.1038/ncpendmet0262
73. Schwartz C, Stevenson RE. The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome. Best Pract Res Clin Endocrinol Metab (2007) 21(2):307-21. doi:10.1016/j.beem.2007.03.009
74. Friesema ECH, Visser WE, Visser TJ. Genetics and phenomics of thyroid hormone transport by MCT8. Mol Cell Endocrinol (2010) 322:107-13. doi:10.1016/j.mce.2010.01.016
75. Bianco AC, Kim BW. Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest (2006) 116(10):2571-9. doi:10.1172/JCI29812
76. Schneider MJ, Fiering SN, Pallud SE, Parlow AF, Germain DLS, Galton VA. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol (2001) 15:2137-48. doi:10.1210/me.15.12.2137
77. Tata JR. The road to nuclear receptors of thyroid hormone. Biochim Biophys Acta (2013) 1830(7):3860-6. doi:10.1016/j.bbagen.2012.02.017
78. Ercan-Fang S, Schwartz HL, Oppenheimer JH. Isoform-specific 3,5,3'-triiodothyronine receptor binding capacity and messenger ribonucleic acid content in rat adenohypophysis: effect of thyroidal state and comparison with extrapituitary tissues. Endocrinology (1996) 137:3228-33. doi:10.1210/endo.137.8.8754744
79. Gil-Ibanez P, Morte B, Bernal J. Role of thyroid hormone receptor subtypes alpha and beta on gene expression in the cerebral cortex and striatum of postnatal mice. Endocrinology (2013) 154:1940-7. doi:10.1210/en.2012-2189
80. Bradley DJ, Young WS, Weinberger C. Differential expression of alpha and beta thyroid hormone receptor genes in rat brain and pituitary. Proc Natl Acad Sci U S A (1989) 86(18):7250-4. doi:10.1073/pnas.86.18.7250
81. Strait KA, Schwartz HL, Seybokd VS, Ling NC, Oppenheimer JH. Immunofluorescence localization of thyroid hormone receptor protein beta 1 and variant alpha 2 in selected tissues: cerebellar Purkinje cells as a model for beta 1 receptor-mediated developmental effects of thyroid hormone in brain. Proc Natl Acad Sci U S A (1991) 88:3887-91. doi:10.1073/pnas.88.9.3887
82. Mellström B, Naranjo JR, Santos A, Gonzalez AM, Bernal J. Independent expression of the alpha and beta c-erbA genes in developing rat brain. Mol Endocrinol (1991) 5:1339-50. doi:10.1210/mend-5-9-1339
83. Gauthier K, Chassande O, Plateroti M, Roux JP, Legrand C, Pain B, et al. Different functions for the thyroid hormone receptors TRalpha and TRbeta in the control of thyroid hormone production and post-natal development. EMBO J (1999) 18:623-31. doi:10.1093/emboj/18.3.623
84. Flamant F, Samarut J. Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol Metab (2003) 14:85-90. doi:10.1016/S1043-2760(02)00043-7
85. Usala SJ, Menke JB, Watson TL, Wondisford FE, Weintraub BD, Berard J, et al. A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor. Mol Endocrinol (1991) 5:327-35. doi:10.1210/mend-5-3-327
86. Dong H, Yauk CL, Rowan-Carroll A, You SH, Zoeller RT, Lambert I, et al. Identification of thyroid hormone receptor binding sites and target genes using ChIP-on-chip in developing mouse cerebellum. PLoS One (2009) 4(2):e4610. doi:10.1371/journal.pone.0004610
87. Gagne R, Green JR, Dong H, Wade MG, Yauk CL. Identification of thyroid hormone receptor binding sites in developing mouse cerebellum. BMC Genomics (2013) 14:341. doi:10.1186/1471-2164-14-341
88. Chatonnet F, Guyot R, Benoit G, Flamant F. Genome-wide analysis of thyroid hormone receptors shared and specific functions in neural cells. Proc Natl Acad Sci U S A (2013) 110(8):E766-75. doi:10.1073/pnas.1210626110
89. Bochukova E, Schoenmakers N, Agostini M, Schoenmakers E, Rajanayagam O, Keogh JM, et al. A mutation in the thyroid hormone receptor alpha gene. N Engl J Med (2012) 366:243-9. doi:10.1056/NEJMoa1110296
90. van Mullem A, van Heerebeek R, Chrysis D, Visser E, Medici M, Andrikoula M, et al. Clinical phenotype and mutant TRa1. N Engl J Med (2012) 366:1451-3. doi:10.1056/NEJMc1113940
91. Weiss RE, Xu J, Ning GJ, O'Malley B, Refetoff SV. Mice deficient in the steroid receptor coactivator 1 (SRC-1) are resistant to thyroid hormone. EMBO J (1999) 18:1900-4. doi:10.1093/emboj/18.7.1900
92. Mahajan MA, Samuels HH. Nuclear hormone receptor coregulator: role in hormone action, metabolism, growth, and development. Endocr Rev (2005) 26(4):583-97. doi:10.1210/er.2004-0012